Mar 22, 2017
Hologic Completes Acquisition of Cynosure
-- Transaction Provides Entry into Large, Fast-Growing Medical Aesthetics Market, Boosts Hologic's Growth Rate --
Hologic, Inc. (Nasdaq: HOLX) announced today that it has completed the acquisition of Cynosure, Inc., a leader in medical aesthetics systems and technologies, for $66 per share in cash. "We are...
Mar 1, 2017
Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017
--Comprehensive suite of transformative products spotlights Hologic’s ongoing dedication to innovation and the advancement of breast health --
MARLBOROUGH, Mass., March 1, 2017 — Hologic, Inc. (Nasdaq: HOLX) will highlight its portfolio of innovative, award-winning breast cancer screening and interventional products, including new...
Feb 15, 2017
FDA Grants PMA Approval for Hologic's Aptima® Hepatitis C Quant Dx Assay
HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther system
Hologic, Inc. (Nasdaq: HOLX) announced today that the United States Food and Drug Administration (FDA) has granted PMA approval for the Company's hepatitis C virus (HCV) assay for quantitation of...
Feb 14, 2017
Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses
-Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate -
Hologic, Inc. (Nasdaq: HOLX), a leader in women's health, and Cynosure, Inc. (Nasdaq: CYNO), a leader in medical aesthetics systems and technologies, announced today they have signed a definitive...
Feb 14, 2017
Hologic's Aptima® Zika Virus Assay Now CE Marked in Europe
--New Diagnostic Test Available for Use on the Panther System--
MARLBOROUGH, Mass., February 13, 2017 -- Hologic, Inc. (NASDAQ: HOLX) today announced the Company's Aptima® Zika Virus diagnostic assay is now CE marked in Europe for the detection and diagnosis...